Taken together, EBI2 and CH25H have profound effects on the intestinal immune system; however, the role of the EBI2-oxysterol axis on the intestinal microbiota in health and disease (e.g., NASH) is unknown, justifying a detailed investigation. The gene discussed is GPR183; the disease is metabolic dysfunction-associated steatohepatitis.